zanamivir has been researched along with Communicable Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiwara, M; Hara, A; Hara, K; Kobayashi, C; Komeda, T; Miyazawa, S; Ogura, E; Urushihara, H; Yoshida, M | 1 |
1 other study(ies) available for zanamivir and Communicable Diseases
| Article | Year |
|---|---|
Comparison of the incidence of bleeding between baloxavir marboxil and other anti-influenza drugs among outpatients with influenza virus infection: A retrospective cohort study using an employment-based health insurance claims database in Japan.
Topics: Antiviral Agents; Communicable Diseases; Dibenzothiepins; Employment; Humans; Incidence; Influenza, Human; Insurance, Health; Japan; Morpholines; Oseltamivir; Outpatients; Pyridones; Retrospective Studies; Triazines; Zanamivir | 2022 |